NEW YORK (Reuters Health) – Urinary tract infections occur quite often after patients are given detrusor injections of botulinum toxin A (BoNT-A) to reduce bladder overactivity, so prophylactic…
NEW YORK (Reuters Health) – When children with overactive bladder have a poor response to medical therapy, a course of transcutaneous electrical nerve stimulation (TENS) applied to the…
NEW YORK (Reuters Health) – The optimal choice of transurethral procedure for benign prostatic hyperplasia is not made much easier by a new meta-analysis, published online June 11…
NEW YORK (Reuters Health) – For locally advanced and metastatic prostate cancer, the best timing and duration of androgen-deprivation therapy (ADT) is unclear. Now, a systematic review suggests…
NEW YORK (Reuters Health) – High-power laser vaporization is a safe and effective alternative to transurethral resection of the prostate (TURP) for benign prostatic hyperplasia, results of a…
NEW YORK (Reuters Health) – For benign prostatic hyperplasia (BPH), monopolar transurethral resection of the prostate (TURP) is being increasingly challenged as the gold standard. Two randomized controlled…
NEW YORK (Reuters Health) Pelvic floor muscle training (PFMT) during individual physical therapy sessions and home exercise can improve pelvic organ prolapse, researchers from Norway report in the…
NEW YORK (Reuters Health) – Mounting evidence suggests that preoperative prostate specific antigen (PSA) kinetics are a poor marker of disease progression. During active surveillance for low-risk, low-volume…
NEW YORK (Reuters Health) – Low-intensity extracorporeal shockwave therapy (LI-ESWT) can improve erectile function, according to a pilot study from Israel. Twice a week for 3 weeks, 20…
NEW YORK (Reuters Health) – Intravesical botulinum toxin improves overactive bladder symptoms, but with a significant risk of urinary retention, according to a meta-analysis reported April 19th in…